prednisone and Body Weight studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

Excerpt	Relevance	Reference
"Methotrexate has been steroid sparing for some patients with chronic sarcoidosis."	9.09	Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. ( Baughman, RP; Lower, EE; Winget, DB, 2000)
"We evaluated growth six to seven years after alternate-day treatment with prednisone had been discontinued in 224 children 6 to 14 years of age with cystic fibrosis who had participated in a multicenter trial of this therapy from 1986 through 1991."	9.09	Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. ( Allen, DB; Campbell, PW; Farrell, PM; FitzSimmons, SC; Kosorok, MR; Lai, HC; Rosenstein, BJ, 2000)
"The long-term anti-inflammatory and immunosuppressive properties and the safety of deflazacort (Calcort, CAS 14484-47-0) were assessed investigating the effect on clinical symptoms and safety parameters in patients with rheumatoid arthritis compared to prednisone as standard therapy in a randomized double-blind controlled clinical trial."	9.07	Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. ( Eberhardt, R; Gross, W; Krüger, K; Reiter, W; Zwingers, T, 1994)
"We previously reported the results of a randomized, double-blind 6-month trial of prednisone therapy in which 102 boys aged 5 to 15 years with Duchenne muscular dystrophy received daily doses of 1."	9.07	A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. ( Brooke, MH; Fenichel, GM; Griggs, RC; King, W; Mendell, JR; Miller, JP; Moxley, RT; Pestronk, A; Robison, J; Signore, L, 1991)
"Retrospective growth data were evaluated for 82 asthmatic children (59% dependent on oral corticosteroids) receiving triamcinolone acetonide aerosol for 1 year."	9.06	A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth patterns of asthmatic children. ( Brown, DC; Letizia, CM; Savacool, AM, 1989)
"A randomised, double-blind, placebo-controlled study examined the effects of alternate-day prednisone therapy on morbidity and progression of lung disease in cystic fibrosis (CF)."	9.05	Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. ( Auerbach, HS; Colten, HR; Kirkpatrick, JA; Williams, M, 1985)
"(1) Diquat can cause kidney damage in rats, mainly manifested as renal tubular atrophy, epithelial cell edema, capillary congestion and dilation, and the renal function damage indicators have been improved to varying degrees."	8.31	Study on the therapeutic effect of glucocorticoids on acute kidney injury in rats exposed to diquat. ( Cui, S; Jian, X; Kan, B; Li, Q; Shi, L; Sun, C; Wang, C; Zhang, X, 2023)
"The current guidelines recommend a dosage of prednisone of 60 mg/m(2) body surface area per day (BSA PRED) for the initial therapy of nephrotic syndrome (NS)."	7.75	Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent? ( Al-Matrafi, J; Farhadi, E; Feber, J; Vaillancourt, R; Wolfish, N, 2009)
"Losartan had an inhibitory effect on bleomycin-induced pulmonary fibrosis, and its effect may be associated with its anti-free radicals and the reduction in TGF-beta1."	7.73	Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. ( Lu, Y; Yao, HW; Zhao, MH; Zhu, JP, 2006)
"Seven children from 3 to 14 years old with chronic steroid-dependent asthma were treated with methotrexate (MTX)."	7.68	Methotrexate treatment of severe asthma in children. ( Guss, S; Portnoy, J, 1992)
"Four children with juvenile osteopetrosis are described who were treated with a combination of prednisone and a low calcium, high phosphate diet."	7.67	Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet. ( Dorantes, LM; Dorantes, S; Mejia, AM, 1986)
"Extrapulmonary effects of alternate-day prednisone and inhaled beclomethasone dipropionate therapy were examined in 24 and 32 children with asthma, respectively."	7.67	Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. ( Brown, K; Nassif, E; Sherman, B; Weinberger, M, 1987)
"We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate."	7.67	Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. ( DeSilva, S; Drachman, DB; Kuncl, RW; Mellits, D, 1987)
" The results suggest that (i) DFC and PRED in equal anti-inflammatory dosage are similarly or equally efficient in slowing down the decline of muscle strength in DMD; (ii) benefits outweigh the side effects."	6.68	Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study. ( Reitter, B, 1995)
"the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking."	5.37	The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. ( Caporali, R; Cimmino, MA; Montecucco, C; Parodi, M, 2011)
" The prodrug fosdagrocorat (PF-04171327), with active DAGR metabolite PF-00251802 (Metabolite-1), is postulated to show superior efficacy over placebo and prednisone in patients with moderate to severe rheumatoid arthritis (RA)."	5.27	Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis. ( McFadyen, L; Tammara, B; Weatherley, B, 2018)
"Pharmacokinetics of 8 doses of rituximab (375 mg/m(2)) given in combination with 2-week cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone/prednisolone (CHOP-14) was determined by ELISA in 20 elderly patients with diffuse large B-cell lymphoma (DLBCL) 10 minutes before and after each infusion and 1 week and 1, 2, 3, 6, and 9 months after the last infusion."	5.16	The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. ( Held, G; Lengfelder, E; Metzner, B; Müller, C; Murawski, N; Nickenig, C; Peter, N; Pfreundschuh, M; Poeschel, V; Reiser, M; Rixecker, T; Wenger, M; Wiesen, MH; Zeynalova, S; Zwick, C, 2012)
"We evaluated growth six to seven years after alternate-day treatment with prednisone had been discontinued in 224 children 6 to 14 years of age with cystic fibrosis who had participated in a multicenter trial of this therapy from 1986 through 1991."	5.09	Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. ( Allen, DB; Campbell, PW; Farrell, PM; FitzSimmons, SC; Kosorok, MR; Lai, HC; Rosenstein, BJ, 2000)
"Methotrexate has been steroid sparing for some patients with chronic sarcoidosis."	5.09	Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. ( Baughman, RP; Lower, EE; Winget, DB, 2000)
"The long-term anti-inflammatory and immunosuppressive properties and the safety of deflazacort (Calcort, CAS 14484-47-0) were assessed investigating the effect on clinical symptoms and safety parameters in patients with rheumatoid arthritis compared to prednisone as standard therapy in a randomized double-blind controlled clinical trial."	5.07	Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. ( Eberhardt, R; Gross, W; Krüger, K; Reiter, W; Zwingers, T, 1994)
"We previously reported the results of a randomized, double-blind 6-month trial of prednisone therapy in which 102 boys aged 5 to 15 years with Duchenne muscular dystrophy received daily doses of 1."	5.07	A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. ( Brooke, MH; Fenichel, GM; Griggs, RC; King, W; Mendell, JR; Miller, JP; Moxley, RT; Pestronk, A; Robison, J; Signore, L, 1991)
"The incidence of posttransplant diabetes mellitus (PTDM) was compared in three groups of renal transplant recipients: nondiabetic patients who had been randomized between 1980 and 1983 to receive antilymphoblast globulin (ALG), azathioprine (AZA), and prednisone (P) (group 1) or cyclosporine (CsA) plus prednisone (group 2)."	5.06	The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. ( Ascher, N; Boudreaux, JP; Canafax, DM; Fryd, DS; McHugh, L; Najarian, JS; Payne, W; Simmons, RL; Sutherland, DE, 1987)
"Retrospective growth data were evaluated for 82 asthmatic children (59% dependent on oral corticosteroids) receiving triamcinolone acetonide aerosol for 1 year."	5.06	A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth patterns of asthmatic children. ( Brown, DC; Letizia, CM; Savacool, AM, 1989)
"A randomised, double-blind, placebo-controlled study examined the effects of alternate-day prednisone therapy on morbidity and progression of lung disease in cystic fibrosis (CF)."	5.05	Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. ( Auerbach, HS; Colten, HR; Kirkpatrick, JA; Williams, M, 1985)
"(1) Diquat can cause kidney damage in rats, mainly manifested as renal tubular atrophy, epithelial cell edema, capillary congestion and dilation, and the renal function damage indicators have been improved to varying degrees."	4.31	Study on the therapeutic effect of glucocorticoids on acute kidney injury in rats exposed to diquat. ( Cui, S; Jian, X; Kan, B; Li, Q; Shi, L; Sun, C; Wang, C; Zhang, X, 2023)
" acidophilus and prednisone acetate) protected against colitis-induced weight loss (P < 0."	3.79	Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. ( Chen, LL; Li, FJ; Lian, GH; Lu, FG; Zou, YY, 2013)
"Although prednisone is the treatment of choice for nephrotic syndrome (NS) in childhood, the dosing regimen varies between 60 mg/m(2)/day, as recommended in early studies, to the often prescribed 2 mg/kg/day dose, which is used in common practice."	3.77	Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? ( Baracco, R; Jain, A; Kapur, G; Mattoo, TK; Saadeh, SA; Valentini, RP, 2011)
"Losartan had an inhibitory effect on bleomycin-induced pulmonary fibrosis, and its effect may be associated with its anti-free radicals and the reduction in TGF-beta1."	3.73	Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. ( Lu, Y; Yao, HW; Zhao, MH; Zhu, JP, 2006)
"Disease duration and cumulative dose of prednisone in children with polyarticular JIA are risk factors of stunted growth and decreased QUS values of bone quality."	3.73	Quantitative ultrasonometry of the calcaneus in children with juvenile idiopathic arthritis. ( Bayer, M; Dolezalova, P; Kutilek, S; Nemcova, D, 2006)
" Cyclosporine A plus steroid-based immuno-suppression regimens in these patients are associated with the development of hypertension, hyperlipidemia, obesity, and diabetes mellitus."	3.69	Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). ( Canzanello, VJ; Krom, RA; Porayko, MK; Schwartz, L; Taler, SJ; Textor, SC; Wiesner, RH, 1997)
"Seven children from 3 to 14 years old with chronic steroid-dependent asthma were treated with methotrexate (MTX)."	3.68	Methotrexate treatment of severe asthma in children. ( Guss, S; Portnoy, J, 1992)
"The severity and persistence of corticosteroid-induced obesity were evaluated retrospectively in 23 children aged 1-14 yrs requiring more than 60 days of therapy with prednisone for idiopathic nephrotic syndrome."	3.67	Corticosteroid therapy-induced obesity in children. ( Hack, SL; Kalsch, M; Merritt, RJ; Olson, D, 1986)
"We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate."	3.67	Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. ( DeSilva, S; Drachman, DB; Kuncl, RW; Mellits, D, 1987)
"Four children with juvenile osteopetrosis are described who were treated with a combination of prednisone and a low calcium, high phosphate diet."	3.67	Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet. ( Dorantes, LM; Dorantes, S; Mejia, AM, 1986)
"Extrapulmonary effects of alternate-day prednisone and inhaled beclomethasone dipropionate therapy were examined in 24 and 32 children with asthma, respectively."	3.67	Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. ( Brown, K; Nassif, E; Sherman, B; Weinberger, M, 1987)
"Excellent clinical results were obtained in 85 patients with chronic asthma who took corticosteroids (mostly triamcinolone) on a long-term basis for periods varying from one to 26 years."	3.66	"Steroid-phobia" in asthma management. ( Tuft, L, 1979)
" It was concluded that: (1) androstenedione, testosterone, free testosterone index, and adrenal androgens alone or in combination play a role in the pathogenesis of the hirsutism observed in eumenorrheic women and in the amenorrhea and oligomenorrhea of both hirsute and nonhirsute women; (2) body weight correlated with adrenal adrogens (17-ketosteroids) in nonhirsute women and with androstenedione in hirsute women; (3) prednisone significantly suppressed androstenedione and 17-ketosteroids (p less than 0."	3.66	Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women. ( Ho Yuen, B; Mincey, EK, 1983)
"16-beta-Metilprednisone was administered in the last week of pregnancy in order to study its effects on postnatal brain development of the litters."	3.65	Prednisone effects on postnatal brain development of rats following maternal therapy. ( Bernasconi, MV; Gioia, IA; Romano, MC, 1977)
"The effects of specific doses of alternate-day treatment with prednisone on linear growth were evaluated in children with severe asthma."	3.65	Growth of asthmatic children during treatment with alternate-day steriods. ( Ellis, EF; Morris, HG; Reimer, LG, 1975)
" Combined therapy with high doses of prednisone and tetracycline hydrochloride resulted in weight gain, cessation of diarrhea, improved absorption of water, fat, and vitamin B12, and production of gastric acid after stimulation with histamine."	3.65	Gastrointestinal dysfunction in immunoglobulin deficiency. Effect of corticosteroids and tetracycline. ( Diaz-Buxo, JA; Hermans, PE; Huizenga, KA, 1975)
" The most frequent adverse events in all 3 active treatment arms were Cushingoid appearance, erythema, hirsutism, increased weight, headache, and nasopharyngitis."	2.82	Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy. ( Cwik, V; Dubow, JS; Fehlings, DL; Florence, JM; Greenberg, CR; Griggs, RC; King, W; Kissel, JT; Mendell, JR; Meyer, JM; Miller, JP; Moxley, RT; Pandya, S; Pestronk, A; Vanasse, M, 2016)
" The acyclovir dosage was 2400 mg (800 mg three times a day) for 10 days, and prednisone was given as a single daily dose of 1 mg/kg of body weight for 10 days and tapered to 0 over the next 6 days."	2.69	Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. ( De Diego, JI; De Sarriá, MJ; Gavilán, J; Madero, R; Prim, MP, 1998)
" The results suggest that (i) DFC and PRED in equal anti-inflammatory dosage are similarly or equally efficient in slowing down the decline of muscle strength in DMD; (ii) benefits outweigh the side effects."	2.68	Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study. ( Reitter, B, 1995)
"It is well known that long-term use of steroids plays a decisive role in the development of glucose intolerance and diabetes mellitus (DM)."	2.68	Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. ( Han, DS; Kim, MS; Kim, SI; Kim, YS; Lee, HY; Lim, SK; Park, K, 1997)
"Prednisone treatment causes protein wasting and adds additional risks to a patient, whereas human growth hormone (hGH) treatment causes positive nitrogen balance."	2.67	Human growth hormone prevents the protein catabolic side effects of prednisone in humans. ( Haymond, MW; Horber, FF, 1990)
" Total prednisone dosage was identical during the 6-mo study periods and only dose spacing differed."	2.65	Comparison of daily and alternate-day prednisone during chronic maintenance therapy: a controlled crossover study. ( Curtis, JJ; Galla, JH; Luke, RG; Saykaly, RJ; Woodford, SY, 1981)
"Body weight was the only risk factor found to be associated with statistically significant differences in survival."	2.65	Body weight and prognosis in breast cancer. ( Boyd, NF; Campbell, JE; Germanson, T; Meakin, JW; Sutherland, DJ; Thomson, DB, 1981)
"Treatment with prednisone was associated with greater weight gain (β = 0."	1.43	Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis. ( Baker, JF; Cannella, A; Cannon, GW; Caplan, L; Davis, L; Ibrahim, S; Jorgenson, E; Michaud, K; Mikuls, TR; Sauer, BC; Teng, CC, 2016)
" Daily prednisone dosing predicted lighter weight, but longer duration, and greater dosages predicted heavier weight."	1.43	Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy. ( Ciafaloni, E; DiGuiseppi, C; James, K; Lamb, MM; Ouyang, L; Pandya, S; Weitzenkamp, D; West, NA; Yang, M, 2016)
" Findings suggest low comparative bioavailability of oral prednisone compared to prednisolone in cats and consideration of lean body mass or ideal body weight for dosing practices."	1.39	Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration. ( Center, SA; Randolph, JF; Rishniw, M; Simpson, KW; Warner, KL, 2013)
"Prednisone treatment delays the progressive course of Duchenne muscular dystrophy."	1.38	Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen. ( de Groot, IJ; Hendriks, JC; Noordam, C; Sie, LT; ten Dam, K; van Alfen, N, 2012)
"2 years; dosing regimen prednisone 0."	1.38	Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. ( Collins, J; Cripe, LH; Hor, KN; Rose, SR; Rutter, MM; Sawnani, H; Sucharew, H; Wong, BL; Woo, JG, 2012)
"the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking."	1.37	The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. ( Caporali, R; Cimmino, MA; Montecucco, C; Parodi, M, 2011)
"A total of 49 boys with Duchenne muscular dystrophy, between the age of 12 and 15 yrs, who were observed over a 7-yr period were reviewed retrospectively."	1.33	Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. ( Balaban, B; Carry, T; Clayton, GH; Matthews, DJ, 2005)
" Cox multivariate analysis included: donor age, sex, and weight; recipient sex, age, pre-HT diagnosis, hypertension, diabetes and hyperlipidemia post-HT; number of treated rejections and RS; and immunosuppressive dosage at 3, 6, and 12 months."	1.32	Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. ( Angelini, A; Caforio, AL; Feltrin, G; Fortina, AB; Gambino, A; Gerosa, G; Iliceto, S; Piaserico, S; Ramondo, A; Thiene, G; Tona, F; Valente, M, 2004)
" When prednisone dosage was tapered from 10 mg/d to 10 mg every other day, clinically significant improvements were seen in weight, systolic and diastolic blood pressure, blood pressure medications, glycosylated hemoglobin level, and diabetic medications."	1.31	Lack of long-term benefits of steroid withdrawal in renal transplant recipients. ( Landsberg, D; Nussbaumer, G; Sivaraman, P, 2001)
"Deflazacort (DFC) is a heterocyclic glucocorticoid with anti-inflammatory activity but with decreased side effects."	1.29	Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies. ( Coirini, H; De Nicola, AF; Flores, D; Gonzalez Deniselle, MC; Vega, MC, 1994)
"Obesity is accompanied by altered secretion and disposition of sex and glucocorticoid hormones, including cortisol, and also confounds parameter normalization and drug dosage selection relative to body weight."	1.27	Prednisolone disposition in obese men. ( Jusko, WJ; Milsap, RL; Plaisance, KI, 1984)
"All patients had ileal strictures with ileocolitis, bone ages less than 13, Tanner stages 1 or 2, and growth velocities below the 3rd percentile for age."	1.27	Influence of preoperative parenteral alimentation on postoperative growth in adolescent Crohn's disease. ( Kim, S; Lake, AM; Mathis, RK; Walker, WA, 1985)
"Hyperlipidemia was observed between the 4th month and the end of the first year after transplantation in 83% of the patients."	1.26	Hyperlipidemias in patients with kidney transplants. ( Brunner, F; Harder, F; Kobza, K; Stähelin, HB; Thiel, G, 1976)
"There is no proved effective treatment of calcinosis which results in functional recovery."	1.26	[Prognosis and current treatment of dermatomyositis]. ( Sánchez Yus, E, 1977)
"Twenty-eight cases of intraoral pemphigus vulgaris are presented."	1.26	Intraoral pemphigus vulgaris. ( Zegarelli, DJ; Zegarelli, EV, 1977)
"Ileocolitis was the most (52%) and colitis the least (9%) common form of disease with diffuse small bowel or ileal disease each comprising nearly 20% of the study group."	1.26	Prognosis in children with Crohn's disease. ( Gryboski, JD; Spiro, HM, 1978)
"The growth of 37 children with ulcerative colitis have been analyzed."	1.25	Growth retardation in children with ulcerative colitis: the effect of medical and surgical therapy. ( Berger, M; Gribetz, D; Korelitz, BI, 1975)

Research

Studies (207)

Authors

Clinical Trials (9)

Trial Overview

Trial Outcomes

Expression of GALGT2 as Demonstrated by Immunofluorescent Staining With Anti-CT Epitope Antibodies or WFA Lectin in Muscle Biopsy Sections at 120 Days Post Injection (Cohort 1) and 90 Days Post-injection (Cohort 2).

Timeframe	Studies, this research(%)	All Research%
pre-1990	131 (63.29)	18.7374
1990's	34 (16.43)	18.2507
2000's	18 (8.70)	29.6817
2010's	22 (10.63)	24.3611
2020's	2 (0.97)	2.80

Authors	Studies
Wang, C	2
Cui, W	1
Zhao, M	1
Yang, J	1
Peng, S	1
Cui, S	1
Zhang, X	1
Sun, C	1
Shi, L	1
Kan, B	1
Li, Q	1
Jian, X	1
Machado, MPR	1
Schavinski, AZ	1
Deluque, AL	1
Volpato, GT	1
Campos, KE	1
Weatherley, B	1
McFadyen, L	1
Tammara, B	1
Yang, YJ	1
Zhu, Z	1
Wang, DT	1
Zhang, XL	1
Liu, YY	1
Lai, WX	1
Mo, YL	1
Li, J	1
Liang, YL	1
Hu, ZQ	1
Yu, YJ	1
Cui, L	2
Jamois, C	1
Gibiansky, E	1
Gibiansky, L	1
Buchheit, V	1
Sahin, D	1
Cartron, G	1
Marcus, R	1
Hiddemann, W	1
Seymour, JF	1
Strefford, JC	1
Hargreaves, CE	1
Meneses-Lorente, G	1
Frey, N	1
Fingerle-Rowson, G	1
Center, SA	1
Randolph, JF	1
Warner, KL	1
Simpson, KW	1
Rishniw, M	1
Chen, LL	1
Zou, YY	1
Lu, FG	1
Li, FJ	1
Lian, GH	1
Lin, S	1
Huang, J	1
Zheng, L	1
Liu, Y	1
Liu, G	1
Li, N	1
Wang, K	1
Zou, L	1
Wu, T	1
Qin, L	1
Li, G	1
Baker, JF	1
Sauer, BC	1
Cannon, GW	1
Teng, CC	1
Michaud, K	1
Ibrahim, S	1
Jorgenson, E	1
Davis, L	1
Caplan, L	1
Cannella, A	1
Mikuls, TR	1
Sinha, S	1
Uchibe, K	1
Usami, Y	1
Pacifici, M	1
Iwamoto, M	1
Carli, AV	1
Harvey, EJ	1
Azeddine, B	1
Gao, C	1
Li, Y	1
Li, A	1
Sayegh, M	1
Wang, H	2
Nahal, A	1
Michel, RP	1
Henderson, JE	1
Séguin, C	1
Lamb, MM	1
West, NA	1
Ouyang, L	1
Yang, M	1
Weitzenkamp, D	1
James, K	1
Ciafaloni, E	1
Pandya, S	2
DiGuiseppi, C	1
Griggs, RC	3
Miller, JP	2
Greenberg, CR	1
Fehlings, DL	1
Pestronk, A	2
Mendell, JR	2
Moxley, RT	3
King, W	2
Kissel, JT	1
Cwik, V	1
Vanasse, M	1
Florence, JM	1
Dubow, JS	1
Meyer, JM	1
Pettengell, R	1
Bosly, A	1
Szucs, TD	1
Jackisch, C	1
Leonard, R	1
Paridaens, R	1
Constenla, M	1
Schwenkglenks, M	1
Feber, J	1
Al-Matrafi, J	1
Farhadi, E	1
Vaillancourt, R	1
Wolfish, N	1
Wang, Z	1
Li, H	1
Xu, H	1
Yue, XL	1
Cheng, XQ	1
Hou, WJ	1
Zhang, YY	1
Chen, DF	1
Mizunoya, W	1
Upadhaya, R	1
Burczynski, FJ	1
Wang, G	1
Anderson, JE	1
Cimmino, MA	1
Parodi, M	1
Montecucco, C	1
Caporali, R	1
Berger, G	1
Hardak, E	1
Shaham, B	1
Avitan, E	1
Yigla, M	1
Saadeh, SA	2
Baracco, R	1
Jain, A	1
Kapur, G	1
Mattoo, TK	1
Valentini, RP	2
Mehls, O	1
Hoyer, PF	1
Neuhaus, TJ	1
Laube, GF	1
Müller, C	1
Murawski, N	1
Wiesen, MH	1
Held, G	1
Poeschel, V	1
Zeynalova, S	1
Wenger, M	1
Nickenig, C	1
Peter, N	1
Lengfelder, E	1
Metzner, B	1
Rixecker, T	1
Zwick, C	1
Pfreundschuh, M	1
Reiser, M	1
ten Dam, K	1
de Groot, IJ	1
Noordam, C	1
van Alfen, N	1
Hendriks, JC	1
Sie, LT	1
Rutter, MM	1
Collins, J	1
Rose, SR	1
Woo, JG	1
Sucharew, H	1
Sawnani, H	1
Hor, KN	1
Cripe, LH	1
Wong, BL	1
Hirano, D	1
Fujinaga, S	1
FERRARI, V	1
GINOULHIAC, E	1
MOSCA, MC	1
TENCONI, LT	1
BATES, RW	2
MILLER, RA	1
GARRISON, MM	2
SHEARN, MA	1
GALLETTI, F	1
BRUNI, G	1
EAKINS, D	1
FULTON, T	1
HADDEN, DR	1
MEIER, AH	1
FARNER, DS	1
COSIMI, AB	1
RECKLER, JM	1
WADDELL, WR	1
Caforio, AL	1
Tona, F	1
Fortina, AB	1
Angelini, A	1
Piaserico, S	1
Gambino, A	1
Feltrin, G	1
Ramondo, A	1
Valente, M	1
Iliceto, S	1
Thiene, G	1
Gerosa, G	1
Balaban, B	1
Matthews, DJ	1
Clayton, GH	1
Carry, T	1
Yao, HW	1
Zhu, JP	1
Zhao, MH	1
Lu, Y	1
Chen, L	1
Zhao, Z	1
Zhang, Y	1
Huang, G	1
McAnally, KJ	1
Valentine, VG	1
LaPlace, SG	1
McFadden, PM	1
Seoane, L	1
Taylor, DE	1
Kutilek, S	1
Bayer, M	1
Dolezalova, P	1
Nemcova, D	1
El Haggan, W	1
Hurault de Ligny, B	1
Partiu, A	1
Sabatier, JP	1
Lobbedez, T	1
Levaltier, B	1
Ryckelynck, JP	1
Hasch, E	1
Jarnum, S	2
Tygstrup, N	1
Jones, JH	1
Peters, DK	1
Morgan, DB	1
Coles, GA	1
Mallick, NP	1
Reynafarje, C	1
Faura, J	1
Lindholm, B	1
Růzica, M	1
Schade, RR	1
Van Thiel, DH	2
Gavaler, JS	1
Hoogwerf, BJ	1
Goetz, FC	1
Ho Yuen, B	1
Mincey, EK	1
Milsap, RL	1
Plaisance, KI	1
Jusko, WJ	1
Diliz-Perez, HS	1
McClure, J	1
Bedetti, C	1
Hong, HQ	1
de Santibanes, E	1
Shaw, BW	1
van Thiel, D	1
Iwatsuki, S	1
Starzl, TE	2
Boyd, NF	3
Campbell, JE	1
Germanson, T	1
Thomson, DB	1
Sutherland, DJ	1
Meakin, JW	1
Curtis, JJ	1
Galla, JH	2
Woodford, SY	1
Saykaly, RJ	1
Luke, RG	2
Davisson, NA	1
Westervelt, FB	1
Bolton, WK	1
Belisario, A	1
D'Antuono, G	1
Modiano, A	1
Reinisch, JM	1
Simon, NG	1
Gandelman, R	1
Koukol, SC	1
DeHaven, JI	1
Riggs, DR	1
Lamm, DL	1
Hilbrands, LB	1
Hoitsma, AJ	1
Koene, RA	1
Turner, RT	1
Hannon, KS	1
Greene, VS	1
Bell, NH	1
Rifai, Z	1
Welle, S	1
Lorenson, M	1
Grotz, W	1
Mundinger, A	1
Gugel, B	1
Exner, V	1
Reichelt, A	1
Schollmeyer, P	1
Coirini, H	1
Flores, D	1
Vega, MC	1
Gonzalez Deniselle, MC	1
De Nicola, AF	1
Eberhardt, R	1
Krüger, K	1
Reiter, W	1
Gross, W	1
Zwingers, T	1
Prummel, MF	1
Mourits, MP	1
Blank, L	1
Berghout, A	1
Koornneef, L	1
Wiersinga, WM	1
Petri, M	1
Lakatta, C	1
Magder, L	1
Goldman, D	1
Motil, KJ	1
Grand, RJ	1
Davis-Kraft, L	1
Ferlic, LL	1
Smith, EO	1
Aicardi, G	2
Benso, L	1
Vignolo, M	2
Terragna, A	2
Verrina, E	1
Cordone, G	2
Coppo, R	2
Sernia, O	1
Sardella, ML	1
Di Battista, E	2
Steiger, U	1
Lippuner, K	1
Jensen, EX	1
Montandon, A	1
Jaeger, P	1
Horber, FF	2
Reitter, B	1
Roujeau, JC	1
Kim, YS	1
Kim, MS	1
Kim, SI	1
Lim, SK	1
Lee, HY	1
Han, DS	1
Park, K	1
Canzanello, VJ	1
Schwartz, L	1
Taler, SJ	1
Textor, SC	2
Wiesner, RH	1
Porayko, MK	1
Krom, RA	1
De Diego, JI	1
Prim, MP	1
De Sarriá, MJ	1
Madero, R	1
Gavilán, J	1
Nordborg, E	1
Schaufelberger, C	1
Bosaeus, I	1
Lai, HC	1
FitzSimmons, SC	1
Allen, DB	1
Kosorok, MR	1
Rosenstein, BJ	1
Campbell, PW	1
Farrell, PM	1
Baughman, RP	1
Winget, DB	1
Lower, EE	1
Gómez Dumm, IN	1
Raimondi, C	1
Touceda, L	1
Fassit, JC	1
Ellis, D	1
Sklar, CA	1
Mertens, AC	1
Walter, A	1
Mitchell, D	1
Nesbit, ME	1
O'Leary, M	1
Hutchinson, R	1
Meadows, AT	1
Robison, LL	1
Sivaraman, P	1
Nussbaumer, G	1
Landsberg, D	1
Avilés, A	2
Neri, N	1
Tenore, A	1
Berman, WF	1
Parks, JS	1
Bongiovanni, AM	1
Gryboski, JD	1
Spiro, HM	1
Beaumont, JE	1
Rees, ED	1
Siegel, RR	1
Sandberg, DH	1
Bernstein, CW	1
McIntosh, RM	1
Carr, R	1
Strauss, J	1
Parving, HH	1
Worm, AM	1
Rossing, N	1
Tuft, L	1
Spiro, SG	1
Charman, J	1
Das, I	1
Reid, L	1
Berger, M	1
Gribetz, D	1
Korelitz, BI	1
Zegarelli, DJ	1
Zegarelli, EV	1
Axelsson, C	1
Sánchez Yus, E	1
McMillen, MA	1
Cerra, FB	1
Baliah, T	1
Anthone, S	1
Anthone, R	1
Gunnarsson, R	1
Arner, P	1
Lundgren, G	1
Magnusson, G	1
Ostman, J	1
Groth, CG	1
O'Morain, C	1
Smith, SD	1
Rosen, D	1
Trueworthy, RC	1
Lowman, JT	1
Saldanha, LF	1
Hurst, KS	1
Amend, WJ	1
Lazarus, JM	1
Lowrie, EG	1
Ingelfinger, J	1
Grupe, W	1
Levey, R	1
Stähelin, HB	1
Kobza, K	1
Brunner, F	1
Harder, F	1
Thiel, G	1
Romano, MC	1
Gioia, IA	1
Bernasconi, MV	1
Pennisi, AJ	1
Fiedler, J	1
Lipsey, A	1
Mickey, R	1
Malekzadeh, MH	1
Fine, NR	1
Reimer, LG	1
Morris, HG	2
Ellis, EF	1
Fiegel, VG	1
Diaz-Buxo, JA	1
Hermans, PE	1
Huizenga, KA	1
Broulik, PD	1
Starka, L	1
Dillberger, JE	1
Cronin, NS	1
Carr, GJ	1
Polito, C	1
Di Toro, R	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Short Term Study on the Effect of a Fixed Dose of 12.5 mg of Prednisone as Starting Dose in Polymyalgia Rheumatica[NCT01169597]	Phase 4	60 participants (Actual)	Interventional	2009-01-31	Completed
Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Year[NCT00052936]	Phase 3	1,506 participants (Actual)	Interventional	2001-01-31	Completed
Randomized Phase II Study About the Application of Pegfilgrastim (Neulasta) at Day 2 or Day 4 Within the Treatment in Patients With Aggressive Non-Hodgkin's Lymphoma Aged 61 to 80 Years With 6 or 8 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxor[NCT00726700]	Phase 2	109 participants (Actual)	Interventional	2004-05-31	Completed
Phase I/IIa Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2[NCT03333590]	Phase 1/Phase 2	2 participants (Actual)	Interventional	2017-11-06	Active, not recruiting
[NCT00005436]		0 participants	Observational	1991-09-30	Completed
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen[NCT01603407]	Phase 3	196 participants (Actual)	Interventional	2013-01-31	Completed
NOURISH-T+: A Randomized Control Trial Targeting Parents in Promoting Healthy Eating and Exercise Behaviors in Pediatric Cancer Survivors With Overweight/Obesity[NCT04656496]		520 participants (Anticipated)	Interventional	2020-12-08	Recruiting
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474]		400 participants (Anticipated)	Observational [Patient Registry]	2003-07-31	Recruiting
The Effects of Disease Activity on Resting Energy Expenditure in Subjects With Crohn's Disease: A Cross-sectional Study[NCT03054935]		150 participants (Anticipated)	Observational	2016-07-01	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Percentage of fibers expressing GALGT2 in each biopsy sample. (NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1)

GALGT2 Protein Expression Quantified by Western Blot and Assessed by Densitometry in Muscle Biopsy Tissue at 120 Days Post-injection (Cohort 1) and 90 Days Post-injection (Cohort 2)

Number of Unanticipated Grade III or Higher Treatment-Related Toxicities

Number of Meters Walked During the 6 Minute Walk Test

Intervention	Percentage of Positive Fibers (Number)
Cohort 1 (Minimal Efficacious Dose)	1.95
Cohort 2	1.72

Intervention	ng/mg total protein (Number)
Cohort 1 (Minimal Efficacious Dose)	12
Cohort 2	14.6

Intervention	events (Number)
Cohort 1 (Minimal Efficacious Dose)	0
Cohort 2	0

(NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1) and Day 180 for both cohorts

Score of Muscle Function Using the The North Star Ambulatory Assessment (NSAA).

Intervention	meters (Number)
	Day 90 (Cohort 2) /Day 120 (Cohort 1)	Day 180
Cohort 1 (Minimal Efficacious Dose)	320	324
Cohort 2 (Minimal Efficacious Dose)	405	416

The NSAA provides a score between 0 and 34 where higher numbers represent greater muscle function. (NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24

Strength of the Bilateral Knee Flexors and Extensors During the Maximal Voluntary Isometric Strength Test.

Intervention	score on a scale (Number)
	Day 90/Day 120	Day 180	Month 12	Month 18	Month 24
Cohort 1 (Minimal Efficacious Dose)	16	14	10	6	2
Cohort 2	21	23	23	23	23

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

Intervention	kg (Number)
	Day 90/Day 120-Right Knee Extension	Day 90/Day 120-Right Knee Flexion	Day 90/Day 120- Left Knee Extension	Day 90/Day 120-Left Knee Flexion	Day 180-Right Knee Extension	Day 180-Right Knee Flexion	Day 180-Left Knee Extension	Day 180-Left Knee Flexion	Month 12-Right Knee Extension	Month 12-Right Knee Flexion	Month 12-Left Knee Extension	Month 12-Left Knee Flexion	Month 18-Right Knee Extension	Month 18-Right Knee Flexion	Month 18-Left Knee Extension	Month 18-Left Knee Flexion	Month 24-Right Knee Extension	Month 24-Right Knee Flexion	Month 24-Left Knee Extension	Month 24-Left Knee Flexion
Cohort 1 (Minimal Efficacious Dose)	7.42	6.06	8.78	6.12	7.13	6.1	8.66	6.69	7.49	5.67	7.5	5.32	4.55	6.11	4.96	6.26	5.06	4.41	6.93	4.17
Cohort 2	7.04	8.12	5.9	8.4	9.73	4.24	8.19	5.25	9.85	5.85	8.02	5.12	7.67	6.89	7.34	6.08	9.81	5.04	5.21	4.87

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

Intervention	seconds (Number)
	Day 90/Day 120	Day 180	Month 12	Month 18
Cohort 1 (Minimal Efficacious Dose)	98.2	110.9	144.5	167.8

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24

6 Minute Walk Test

Intervention	seconds (Number)
	Day 90/Day 120	Day 180	Month 12	Month 18	Month 24
Cohort 2	56.1	44.9	44.7	65.6	48.4

Measures the total distance walked in 6 minutes averaged over all post-baseline follow-up visits through Month 36. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Forced Vital Capacity

Intervention	meters (Least Squares Mean)
Daily Prednisone	384.95
Daily Deflazacort	384.17
Intermittent Prednisone	346.81

Forced vital capacity was measured during a spirometry test. Forced expiratory volume (FEV) measures how much air a person can exhale during a forced breath. Forced vital capacity (FVC) is the total amount of air exhaled during the FEV test. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Fractional Shortening Percent

Intervention	liters (Least Squares Mean)
Daily Prednisone	1.4
Daily Deflazacort	1.4
Intermittent Prednisone	1.5

Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months

Heart Rate

Intervention	percentage of fractional shortening (Least Squares Mean)
Daily Prednisone	33.74
Daily Deflazacort	34.01
Intermittent Prednisone	34.33

Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months

Left Ventricular Ejection Fraction Percent

Intervention	bpm (Least Squares Mean)
Daily Prednisone	94.10
Daily Deflazacort	93.52
Intermittent Prednisone	91.65

Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months

North Star Ambulatory Assessment (NSAA) Score

Intervention	percentage of ejection fraction (Least Squares Mean)
Daily Prednisone	61.88
Daily Deflazacort	62.65
Intermittent Prednisone	62.45

"The North Star Ambulatory Assessment (NSAA) is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy (DMD). It is usually used to monitor the progression of the disease and treatment effects.~The activities are graded as follows:~2 - Normal - no obvious modification of activity~1 - Modified method but achieves goal independent of physical assistance from another 0 - Unable to achieve independently This scale is ordinal with 34 as the maximum score indicating fully-independent function." (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Number of Participants Who Tolerated the Regimen

Intervention	score on a scale (Least Squares Mean)
Daily Prednisone	23.7
Daily Deflazacort	24.0
Intermittent Prednisone	20.7

The number of participants who completed 36 months of follow-up on the originally assigned dosage (for weight) of study medication. (NCT01603407)
Timeframe: 3 years

Participant Body Mass Index

Participant Height

Participant Weight

PR Interval

Intervention	Participants (Count of Participants)
Daily Prednisone	36
Daily Deflazacort	36
Intermittent Prednisone	37

Intervention	kilograms/square meter (Least Squares Mean)
Daily Prednisone	18.9
Daily Deflazacort	18.3
Intermittent Prednisone	18.1

Intervention	centimeters (Least Squares Mean)
Daily Prednisone	116.8
Daily Deflazacort	115.3
Intermittent Prednisone	119.9

Intervention	kilograms (Least Squares Mean)
Daily Prednisone	26.3
Daily Deflazacort	24.9
Intermittent Prednisone	26.3

Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months

Quality of Life - Parent

Intervention	milliseconds (Least Squares Mean)
Daily Prednisone	115.59
Daily Deflazacort	116.87
Intermittent Prednisone	117.90

Quality of life was measured by parent/guardian self-report for all children utilizing the PEDSQL measurement tool. This is a 23-question tool. Scores can range from 0 to 100, with higher scores indicating better quality of life for the child. (NCT01603407)
Timeframe: Average of Months 12, 24, and 36 visits

Quality of Life- Child

Intervention	score on a scale (Least Squares Mean)
Daily Prednisone	64.88
Daily Deflazacort	63.71
Intermittent Prednisone	61.33

Quality of life was measured by child self-report in children age 5 and older utilizing the PEDSQL measurement tool. This is a 23-question tool. Scores can range from 0 to 100, with higher scores indicating better quality of life. (NCT01603407)
Timeframe: Average of Months 12, 24, and 36 visits

Range of Motion (Goniometry) of Left Ankle

Intervention	score on a scale (Least Squares Mean)
Daily Prednisone	67.39
Daily Deflazacort	64.96
Intermittent Prednisone	65.07

Range of motion at the ankle joint in dorsiflexion measured in degrees from plantigrade averaged over all post-baseline visits. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Range of Motion (Goniometry) of Right Ankle

Intervention	degrees (Mean)
Daily Prednisone	4.39
Daily Deflazacort	3.29
Intermittent Prednisone	2.67

Rise From the Floor Velocity

Intervention	degrees (Mean)
Daily Prednisone	4.05
Daily Deflazacort	2.81
Intermittent Prednisone	2.29

Reciprocal of time to rise from the floor (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction With Treatment Score

Intervention	rise/sec (Least Squares Mean)
Daily Prednisone	0.24
Daily Deflazacort	0.24
Intermittent Prednisone	0.18

The TSQM Global Satisfaction with Treatment is a 14-item questionnaire that ranges from 0 - 100 with higher scores indicating better outcomes. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits

Article	Year
Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis. Clinical and translational science, 2018, Volume: 11, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Arthritis, Rheu	2018
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy. British journal of clinical pharmacology, 2019, Volume: 85, Issue:7 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydr	2019
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy. Neurology, 2016, Nov-15, Volume: 87, Issue:20 Topics: Adolescent; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Double-Blind Method; Hum	2016
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood, 2012, Apr-05, Volume: 119, Issue:14 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Body W	2012
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood, 2012, Apr-05, Volume: 119, Issue:14 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Body W	2012
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood, 2012, Apr-05, Volume: 119, Issue:14 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Body W	2012
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood, 2012, Apr-05, Volume: 119, Issue:14 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Body W	2012
Body weight and prognosis in breast cancer. Journal of the National Cancer Institute, 1981, Volume: 67, Issue:4 Topics: Adult; Aged; Body Height; Body Weight; Breast Neoplasms; Castration; Female; Hormones; Humans; Menst	1981
Comparison of daily and alternate-day prednisone during chronic maintenance therapy: a controlled crossover study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1981, Volume: 1, Issue:3 Topics: Body Weight; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Hypothalamo-Hyp	1981
The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation, 1995, May-15, Volume: 59, Issue:9 Topics: Adult; Azathioprine; Body Weight; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection;	1995
Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplantation proceedings, 1994, Volume: 26, Issue:5 Topics: Absorptiometry, Photon; Age Factors; Analysis of Variance; Body Weight; Bone Density; Cyclosporine;	1994
Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. Arzneimittel-Forschung, 1994, Volume: 44, Issue:5 Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Weight; Cushing Syndrome; Double-	1994
Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet (London, England), 1993, Oct-16, Volume: 342, Issue:8877 Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Eye Diseases; Female; Graves Disease;	1993
Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation. British journal of rheumatology, 1993, Volume: 32 Suppl 2 Topics: Age Determination by Skeleton; Anti-Inflammatory Agents; Body Height; Body Weight; Child; Child, Pre	1993
Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study. Brain & development, 1995, Volume: 17 Suppl Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Creatine Kinas	1995
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. Transplant international : official journal of the European Society for Organ Transplantation, 1997, Volume: 10, Issue:3 Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Immunosup	1997
Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. The Laryngoscope, 1998, Volume: 108, Issue:4 Pt 1 Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agent	1998
The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis. Scandinavian journal of rheumatology, 1998, Volume: 27, Issue:2 Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Body Composition; Body Mass Index; Body Weight; Double	1998
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. The New England journal of medicine, 2000, Mar-23, Volume: 342, Issue:12 Topics: Adolescent; Body Height; Body Weight; Child; Cystic Fibrosis; Double-Blind Method; Drug Administrati	2000
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2000, Volume: 17, Issue:1 Topics: Adult; Body Weight; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents;	2000
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Medical and pediatric oncology, 2000, Volume: 35, Issue:2 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Mass Inde	2000
Liver transplantation at the University of Pittsburgh, 1984 to 1990. Clinical transplants, 1991 Topics: Adolescent; Age Factors; Body Weight; Child; Child, Preschool; Cyclosporine; Graft Survival; Hepatic	1991
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort. Pediatrics, 1991, Volume: 88, Issue:3 Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Body Height; Body Weight; Bone Density; C	1991
Resting and total energy expenditure in patients with inflammatory bowel disease. The American journal of clinical nutrition, 1991, Volume: 53, Issue:1 Topics: Adult; Analysis of Variance; Anthropometry; Basal Metabolism; Body Weight; Energy Metabolism; Female	1991
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Archives of neurology, 1991, Volume: 48, Issue:6 Topics: Adolescent; Body Weight; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule;	1991
Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis. Calcified tissue international, 1991, Volume: 48, Issue:4 Topics: Age Determination by Skeleton; Body Height; Body Weight; Child; Child, Preschool; Connective Tissue	1991
Human growth hormone prevents the protein catabolic side effects of prednisone in humans. The Journal of clinical investigation, 1990, Volume: 86, Issue:1 Topics: Blood Glucose; Body Weight; Diet; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Ket	1990
Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth. Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 2 Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Child; Clinical Trials as Topic; Cyclos	1989
A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth patterns of asthmatic children. Annals of allergy, 1989, Volume: 63, Issue:1 Topics: Adolescent; Aerosols; Asthma; Body Height; Body Weight; Child; Female; Growth; Humans; Male; Multice	1989
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (London, England), 1985, Sep-28, Volume: 2, Issue:8457 Topics: Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Double	1985
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation, 1987, Volume: 44, Issue:3 Topics: Adult; Antilymphocyte Serum; Azathioprine; Body Weight; Cyclosporins; Diabetes Mellitus; Drug Therap	1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:3 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms;	1987
Prednisone in Duchenne muscular dystrophy. Lancet (London, England), 1974, Dec-14, Volume: 2, Issue:7894 Topics: Activities of Daily Living; Blood Cell Count; Body Weight; Child; Child Health Services; Child, Pres	1974
[Clinical study of a new synthetic steroid in the treatment of bronchial asthma]. Gaceta medica de Mexico, 1972, Volume: 104, Issue:4 Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Asthma; Blood Glucose; Body Weight; Clinica	1972
Early ambulation in the treatment of acute rheumatic fever. A controlled study in children with acute rheumatic fever treated with prednisone. American journal of diseases of children (1960), 1968, Volume: 115, Issue:5 Topics: Acute Disease; Blood Sedimentation; Body Temperature; Body Weight; Child; Chorea; Clinical Trials as	1968

Article	Year
Studies on the synthesis and anti-Osteoporosis of estrogen-GHRPs linkers. Bioorganic & medicinal chemistry letters, 2003, Jan-06, Volume: 13, Issue:1 Topics: Animals; Body Weight; Calcium; Cross-Linking Reagents; Estrogens; Femur; Growth Hormone-Releasing Ho	2003
Study on the therapeutic effect of glucocorticoids on acute kidney injury in rats exposed to diquat. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 166 Topics: Acute Kidney Injury; Animals; Atrophy; Body Weight; Dexamethasone; Diquat; Glucocorticoids; Kidney;	2023
The Treatment of Prednisone in Mild Diabetic Rats: Biochemical Parameters and Cell Response. Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:5 Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glucocorticoids; Glucose Intol	2020
Tanshinol alleviates impaired bone formation by inhibiting adipogenesis via KLF15/PPARγ2 signaling in GIO rats. Acta pharmacologica Sinica, 2018, Volume: 39, Issue:4 Topics: Adipocytes; Adipogenesis; Animals; Body Weight; Bone Marrow; Caffeic Acids; CCAAT-Enhancer-Binding P	2018
Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration. Research in veterinary science, 2013, Volume: 95, Issue:1 Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Body Weight; Cats; Cross-O	2013
Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. World journal of gastroenterology, 2013, Aug-28, Volume: 19, Issue:32 Topics: Animals; Anti-Inflammatory Agents; Body Weight; Colitis; Colon; Dextran Sulfate; Disease Models, Ani	2013
Glucocorticoid-induced osteoporosis in growing rats. Calcified tissue international, 2014, Volume: 95, Issue:4 Topics: Acetates; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Resorption; Densitometry;	2014
Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2016, Volume: 68, Issue:8 Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Body Weight;	2016
Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent. Bone, 2016, Volume: 90 Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cartilage; Cell Movement; Dexamethasone; Disease Mod	2016
Substrain-specific differences in bone parameters, alpha-2-macroglobulin circulating levels, and osteonecrosis incidence in a rat model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2017, Volume: 35, Issue:6 Topics: alpha-Macroglobulins; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Femur Head; Femur	2017
Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy. The Journal of pediatrics, 2016, Volume: 173 Topics: Adolescent; Body Height; Body Mass Index; Body Weight; Case-Control Studies; Child; Child, Preschool	2016
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study. British journal of haematology, 2009, Volume: 144, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclo	2009
Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent? Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:5 Topics: Body Surface Area; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; G	2009
Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of ethnopharmacology, 2009, Jul-30, Volume: 124, Issue:3 Topics: Animals; Antibodies, Bacterial; Autoimmune Diseases; Body Weight; Bupleurum; Campylobacter Infection	2009
Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm. American journal of physiology. Cell physiology, 2011, Volume: 300, Issue:5 Topics: Animals; Body Weight; Calcinosis; Diaphragm; Female; Guaifenesin; Isosorbide Dinitrate; Male; Mice;	2011
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC musculoskeletal disorders, 2011, May-14, Volume: 12, Issue:1 Topics: Administration, Oral; Aged; Analysis of Variance; Biomarkers; Blood Sedimentation; Body Weight; C-Re	2011
Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing. Sleep & breathing = Schlaf & Atmung, 2012, Volume: 16, Issue:2 Topics: Anti-Inflammatory Agents; Body Size; Body Weight; Disease Progression; Dose-Response Relationship, D	2012
Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatric nephrology (Berlin, Germany), 2011, Volume: 26, Issue:12 Topics: Adolescent; Anti-Inflammatory Agents; Body Surface Area; Body Weight; Child; Child, Preschool; Femal	2011
Dosing of glucocorticosteroids in nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2011, Volume: 26, Issue:12 Topics: Anti-Inflammatory Agents; Body Surface Area; Body Weight; Female; Humans; Male; Nephrotic Syndrome;	2011
Weight dosing of steroids in nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2012, Volume: 27, Issue:3 Topics: Anti-Inflammatory Agents; Body Surface Area; Body Weight; Female; Humans; Male; Nephrotic Syndrome;	2012
Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen. Neuromuscular disorders : NMD, 2012, Volume: 22, Issue:6 Topics: Body Height; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies;	2012
Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscular disorders : NMD, 2012, Volume: 22, Issue:12 Topics: Body Height; Body Weight; Child; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Ma	2012
Two dosing regimens for steroid therapy in nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2014, Volume: 29, Issue:2 Topics: Anti-Inflammatory Agents; Body Surface Area; Body Weight; Female; Humans; Male; Nephrotic Syndrome;	2014
Dosing of steroids in small children with nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2014, Volume: 29, Issue:2 Topics: Anti-Inflammatory Agents; Body Surface Area; Body Weight; Female; Humans; Male; Nephrotic Syndrome;	2014
How can I avoid the weight gain that often occurs when taking prednisone? Mayo Clinic women's healthsource, 2003, Volume: 7, Issue:8 Topics: Anti-Inflammatory Agents; Body Weight; Humans; Prednisone; Weight Gain	2003
[Study of the biological activity of prednisone]. Minerva medica, 1955, Jul-04, Volume: 46, Issue:53 Topics: Blood; Body Weight; Eosinophils; Glycogen; Growth; Humans; Leukocyte Count; Liver; Prednisone; Stero	1955
Evidence in the hypophysectomized pigeon of a synergism among prolactin, growth hormone, thyroxine and prednisone upon weight of the body, digestive tract, kidney and fat stores. Endocrinology, 1962, Volume: 71 Topics: Adipose Tissue; Animals; Body Weight; Columbidae; Gastrointestinal Tract; Growth Hormone; Human Grow	1962
NORMOCHOLESTEROLEMIC NEPHROTIC SYNDROME OF SYSTEMIC LUPUS ERYTHEMATOSUS. The American journal of medicine, 1964, Volume: 36 Topics: Adolescent; Body Weight; Chloroquine; Cholesterol; Humans; Hypercholesterolemia; Lupus Erythematosus	1964
[STEROIDAL ETHERS: ANTICATABOLIC EFFECT OF A NON-17 ALPHA-ALKYLATED ANABOLIC STEROID IN RATS TREATED WITH PREDNISONE]. Bollettino della Societa italiana di biologia sperimentale, 1963, Dec-31, Volume: 39 Topics: Adrenal Glands; Anabolic Agents; Body Weight; Castration; Ethers; Female; Genitalia; Genitalia, Male	1963
RETICULUM CELL SARCOMA OF THE SMALL BOWEL AND STEATORRHOEA. Gut, 1964, Volume: 5 Topics: Ascorbic Acid; Blood Transfusion; Body Weight; Bone Marrow Examination; Celiac Disease; Diet; Diet T	1964
A POSSIBLE ENDOCRINE BASIS FOR PREMIGRATORY FATTENING IN THE WHITE-CROWNED SPARROW, ZONOTRICHIA LEUCOPHRYS GAMBELII (NUTTALL). General and comparative endocrinology, 1964, Volume: 4 Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; Birds; Body Weight; Endocrinology; Follicle St	1964
METABOLIC STUDIES ON RENAL HOMOGRAFT PATIENTS. The Journal of surgical research, 1965, Volume: 5 Topics: Allografts; Antimetabolites; Azathioprine; Blood Urea Nitrogen; Body Weight; Dactinomycin; Drug Ther	1965
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:6 Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Body Weight; Coronary Angiography; Coronary Disease;	2004
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. American journal of physical medicine & rehabilitation, 2005, Volume: 84, Issue:11 Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response R	2005
Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration; international review of thoracic diseases, 2006, Volume: 73, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Bleomycin; Body Weigh	2006
Effects of the extract of a Chinese herb Tripterygium wilfordii hook f on rat pituitary gland. The American journal of Chinese medicine, 2005, Volume: 33, Issue:6 Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Corticosterone; Glucocorticoids;	2005
Effect of pre-transplantation prednisone on survival after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:1 Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Child; Cohort Studies; Female; Graft Rejectio	2006
Quantitative ultrasonometry of the calcaneus in children with juvenile idiopathic arthritis. Rheumatology (Oxford, England), 2006, Volume: 45, Issue:10 Topics: Adolescent; Analysis of Variance; Arthritis, Juvenile; Body Height; Body Mass Index; Body Weight; Ca	2006
The evolution of weight and body composition in renal transplant recipients: Two-year longitudinal study. Transplantation proceedings, 2006, Volume: 38, Issue:10 Topics: Absorptiometry, Photon; Adrenal Cortex Hormones; Adult; Body Composition; Body Weight; Cadaver; Drug	2006
Albumin synthesis rate as a measure of liver function in patient with cirrhosis. Acta medica Scandinavica, 1967, Volume: 182, Issue:1 Topics: Aged; Albumins; Alkaline Phosphatase; Ascites; Blood Volume Determination; Body Weight; Cholinestera	1967
Observations on calcium metabolism in the nephrotic syndrome. The Quarterly journal of medicine, 1967, Volume: 36, Issue:143 Topics: Adolescent; Adult; Alkaline Phosphatase; Body Weight; Bone Diseases; Calcium; Female; Humans; Hypoca	1967
Erythrokinetics in the treatment of aplastic anemia with methandrostenolone. Archives of internal medicine, 1967, Volume: 120, Issue:6 Topics: Adolescent; Adult; Anemia, Aplastic; Bilirubin; Blood Platelets; Body Weight; Bone Marrow Examinatio	1967
Body cell mass during long-term treatment with cortisone and anabolic steroids in asthmatic subjects. Acta endocrinologica, 1967, Volume: 55, Issue:2 Topics: Adult; Aged; Asthma; Basal Metabolism; Body Fluids; Body Weight; Cortisone; Female; Humans; Male; Mi	1967
[Contribution to case finding of prediabetes in obese children from diabetic families]. Ceskoslovenska pediatrie, 1967, Volume: 22, Issue:8 Topics: Adolescent; Blood Glucose; Body Weight; Child; Child, Preschool; Diabetes Mellitus; Female; Humans;	1967
Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome. Digestive diseases and sciences, 1984, Volume: 29, Issue:7 Topics: Adolescent; Adult; Apgar Score; Body Weight; Colitis, Ulcerative; Female; Fetal Growth Retardation;	1984
Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids. The Journal of clinical endocrinology and metabolism, 1983, Volume: 56, Issue:1 Topics: Adolescent; Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Diet; Dietary Carbohydrates; Dietary	1983
Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women. American journal of obstetrics and gynecology, 1983, Jan-15, Volume: 145, Issue:2 Topics: 17-Ketosteroids; Adult; Amenorrhea; Androgens; Androstenedione; Body Weight; Estradiol; Female; Foll	1983
Prednisolone disposition in obese men. Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:6 Topics: Adolescent; Adult; Blood Proteins; Body Weight; Humans; Hydrocortisone; Kinetics; Male; Obesity; Pre	1984
Successful small bowel allotransplantation in dogs with cyclosporine and prednisone. Transplantation, 1984, Volume: 37, Issue:2 Topics: Animals; Body Weight; Cyclosporins; Dogs; Female; Graft Rejection; Intestinal Absorption; Intestinal	1984
Comparison of alternate day steroids and daily steroids in renal transplant recipients. Proceedings of the Clinical Dialysis and Transplant Forum, 1980, Volume: 10 Topics: Blood Glucose; Blood Pressure; Body Weight; Creatinine; Graft Rejection; Humans; Hyperglycemia; Hype	1980
[Angioimmunoblastic lymphadenopathy. Case report]. Minerva medica, 1982, Dec-22, Volume: 73, Issue:49-50 Topics: Anemia; Body Weight; Female; Fever; Hepatomegaly; Humans; Immunoblastic Lymphadenopathy; Immunosuppr	1982
Prenatal exposure to prednisone permanently alters fighting behavior of female mice. Pharmacology, biochemistry, and behavior, 1980, Volume: 12, Issue:2 Topics: Aggression; Animals; Body Weight; Female; Humans; Maternal Behavior; Maternal-Fetal Exchange; Mice;	1980
Drug therapy of bacillus Calmette-Guérin sepsis. Urological research, 1995, Volume: 22, Issue:6 Topics: Animals; Body Weight; Cycloserine; Drug Combinations; Isoniazid; Mice; Mice, Inbred C3H; Mycobacteri	1995
Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats. Calcified tissue international, 1995, Volume: 56, Issue:4 Topics: Animals; Body Weight; Diaphyses; Female; Osteogenesis; Ovariectomy; Prednisone; Rats; Tibia; Uterus	1995
Effect of prednisone on protein metabolism in Duchenne dystrophy. The American journal of physiology, 1995, Volume: 268, Issue:1 Pt 1 Topics: Adult; Body Weight; Child; Child, Preschool; Hormones; Humans; Muscle Proteins; Muscles; Muscular Dy	1995
Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 49, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Binding, Competitive; Body Weight; Brain; Cerebral Cortex; Cortic	1994
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. The American journal of medicine, 1994, Volume: 96, Issue:3 Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Coronary Disease; Female; Humans; Hydroxychloroquin	1994
Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology, 1993, Volume: 105, Issue:3 Topics: Administration, Oral; Adolescent; Body Height; Body Weight; Child; Female; Growth Disorders; Humans;	1993
Body composition and fuel metabolism after kidney grafting. European journal of clinical investigation, 1995, Volume: 25, Issue:11 Topics: Adipose Tissue; Adult; Basal Metabolism; Body Composition; Body Weight; Bone Density; Calorimetry, I	1995
Pulse glucocorticoid therapy. The 'big shot' revisited. Archives of dermatology, 1996, Volume: 132, Issue:12 Topics: Administration, Oral; Anti-Inflammatory Agents; Biological Availability; Body Weight; Dexamethasone;	1996
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1997, Volume: 3, Issue:1 Topics: Adult; Benzothiadiazines; Blood Glucose; Blood Pressure; Body Weight; Cyclosporine; Diabetes Mellitu	1997
Effect of methyl-prednisone and cyclosporine on the lipid pattern and polyunsaturated fatty acid biosynthesis in the rat. Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia, 1999, Volume: 49, Issue:3 Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Cyclosporine; Fatty Acids, Unsaturated; Immunosupp	1999
Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:7 Topics: Adolescent; Body Height; Body Mass Index; Body Weight; Child; Child Development; Child, Preschool; G	2000
Lack of long-term benefits of steroid withdrawal in renal transplant recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:6 Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Drug	2001
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clinical lymphoma, 2001, Volume: 2, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci	2001
Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:4 Topics: Adolescent; Animals; Body Height; Body Weight; Child; Colitis, Ulcerative; Crohn Disease; Female; Gl	1977
Prognosis in children with Crohn's disease. Gastroenterology, 1978, Volume: 74, Issue:5 Pt 1 Topics: Adolescent; Adult; Body Height; Body Weight; Child; Child, Preschool; Colitis; Crohn Disease; Female	1978
Normal serum-lipids in renal-transplant patients. Lancet (London, England), 1975, Mar-15, Volume: 1, Issue:7907 Topics: Adolescent; Adult; Age Factors; Antigens; Azathioprine; Body Weight; Cholesterol; Creatine; Fasting;	1975
Severe steroid-responsive nephrosis associated with hypersensitivity. Lancet (London, England), 1977, Feb-19, Volume: 1, Issue:8008 Topics: Adolescent; Allergens; Animals; Body Weight; Child; Complement C3; Complement C4; Female; Food Hyper	1977
Plasma volume, intravascular albumin and its transcapillary escape rate in patients with extensive skin disease. The British journal of dermatology, 1976, Volume: 95, Issue:5 Topics: Aged; Body Height; Body Weight; Capillary Permeability; Dermatitis, Exfoliative; Female; Humans; Mal	1976
"Steroid-phobia" in asthma management. Annals of allergy, 1979, Volume: 42, Issue:3 Topics: Acne Vulgaris; Adrenal Cortex Hormones; Asthma; Beclomethasone; Betamethasone; Body Weight; Dose-Res	1979
Bronchorrhoea in a case of alveolar cell carcinoma. Journal of clinical pathology, 1975, Volume: 28, Issue:1 Topics: Adenocarcinoma, Bronchiolo-Alveolar; Atropine; Blood Sedimentation; Body Weight; Bronchoscopy; Cough	1975
Growth retardation in children with ulcerative colitis: the effect of medical and surgical therapy. Pediatrics, 1975, Volume: 55, Issue:4 Topics: Adolescent; Body Weight; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Female; Growth; Gr	1975
Intraoral pemphigus vulgaris. Oral surgery, oral medicine, and oral pathology, 1977, Volume: 44, Issue:3 Topics: Acantholysis; Age Factors; Body Weight; Diagnosis, Differential; Female; Follow-Up Studies; Humans;	1977
Synthetic diet in internal medicine. Zeitschrift fur Ernahrungswissenschaft. Journal of nutritional sciences. Supplementa, 1977, Issue:20 Topics: Adult; Body Weight; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Diseases; Male; Prednison	1977
[Prognosis and current treatment of dermatomyositis]. Medicina cutanea ibero-latino-americana, 1977, Volume: 5, Issue:5 Topics: Adult; Body Weight; Calcinosis; Child; Dermatomyositis; Humans; Prednisone; Prognosis	1977
Swine influenza vaccination in a dialysis and transplant population. Journal of dialysis, 1978, Volume: 2, Issue:5-6 Topics: Adolescent; Adult; Aged; Antibody Formation; Azathioprine; Body Weight; Child; Creatinine; Female; G	1978
Diabetes mellitus--a more-common-than-believed complication of renal transplantation. Transplantation proceedings, 1979, Volume: 11, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Body Weight; Cadaver; Child; Diabetes Mellitus; Female; HLA An	1979
Elemental diets in the treatment of Crohn's disease. The Proceedings of the Nutrition Society, 1979, Volume: 38, Issue:3 Topics: Adolescent; Adult; Body Height; Body Weight; Child; Crohn Disease; Female; Flucytosine; Humans; Male	1979
A reliable method for evaluating drug compliance in children with cancer. Cancer, 1979, Volume: 43, Issue:1 Topics: 17-Ketosteroids; Adolescent; Body Weight; Child; Child, Preschool; Female; Hemoglobins; Humans; Infa	1979
Hyperlipidemia after renal transplantation in children. American journal of diseases of children (1960), 1976, Volume: 130, Issue:9 Topics: Adolescent; Antigens; Blood Glucose; Body Weight; Child; Cholesterol; Creatinine; Female; Humans; Hy	1976
Hyperlipidemias in patients with kidney transplants. Klinische Wochenschrift, 1976, Sep-15, Volume: 54, Issue:18 Topics: Age Factors; Body Weight; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperinsulinism; Hy	1976
Prednisone effects on postnatal brain development of rats following maternal therapy. Pediatric research, 1977, Volume: 11, Issue:10 Pt 1 Topics: Animals; Body Weight; Brain; Female; Lipid Metabolism; Maternal-Fetal Exchange; Nerve Tissue Protein	1977
Hyperlipidemia in pediatric renal allograft recipients. The Journal of pediatrics, 1975, Volume: 87, Issue:2 Topics: Adolescent; Adult; Body Weight; Child; Child, Preschool; Cholesterol; Humans; Hyperlipidemias; Immun	1975
Growth of asthmatic children during treatment with alternate-day steriods. The Journal of allergy and clinical immunology, 1975, Volume: 55, Issue:4 Topics: Age Factors; Asthma; Body Height; Body Weight; Child; Female; Follow-Up Studies; Growth; Humans; Mal	1975
[Compative studies of effects and side effects of hydrocortisone, prednisone, triamcinoline and dexamethasone]. Arzneimittel-Forschung, 1975, Volume: 25, Issue:4 Topics: Body Weight; Dexamethasone; Diabetes Mellitus; Edema; Humans; Hydrocortisone; Peptic Ulcer; Pituitar	1975
Gastrointestinal dysfunction in immunoglobulin deficiency. Effect of corticosteroids and tetracycline. JAMA, 1975, Sep-15, Volume: 233, Issue:11 Topics: Achlorhydria; Adult; Age Factors; Body Weight; Celiac Disease; Cholecystokinin; Diarrhea; Drug Thera	1975
Corticosteroid-like effect of cyproterone and cyproterone acetate in mice. Experientia, 1975, Nov-15, Volume: 31, Issue:11 Topics: Adrenal Glands; Animals; Body Weight; Cyproterone; Male; Mice; Organ Size; Prednisone; Seminal Vesic	1975
Prednisone is not a mouse carcinogen. Toxicologic pathology, 1992, Volume: 20, Issue:1 Topics: Animals; Blood Cell Count; Body Weight; Carcinogens; Female; Male; Mice; Mice, Inbred ICR; Neoplasms	1992
Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone. Child nephrology and urology, 1992, Volume: 12, Issue:4 Topics: Adolescent; Body Height; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Female;	1992
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma. Hormone research, 1992, Volume: 37, Issue:3 Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag	1992
Assessment of body composition in heart transplant patients. Medicine and science in sports and exercise, 1992, Volume: 24, Issue:2 Topics: Adult; Body Composition; Body Weight; Heart Transplantation; Humans; Male; Middle Aged; Postoperativ	1992
Methotrexate treatment of severe asthma in children. Pediatrics, 1992, Volume: 89, Issue:4 Pt 1 Topics: Adolescent; Albuterol; Asthma; Beclomethasone; Body Height; Body Weight; Child; Child, Preschool; Cr	1992
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. American journal of hematology, 1991, Volume: 36, Issue:4 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci	1991
Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood, 1992, Feb-01, Volume: 79, Issue:3 Topics: Adult; Angioedema; Body Weight; Cell Degranulation; Eosinophilia; Eosinophils; Female; Humans; Inter	1992
Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients. Transplantation proceedings, 1991, Volume: 23, Issue:1 Pt 2 Topics: Azathioprine; Body Weight; Cholesterol; Creatinine; Cyclosporins; Humans; Hypertension; Immunosuppre	1991
Growth of lung allografts after experimental transplantation. The Thoracic and cardiovascular surgeon, 1991, Volume: 39, Issue:1 Topics: Animals; Azathioprine; Body Weight; Cyclosporins; Graft Rejection; Immunosuppression Therapy; Lung;	1991
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer, 1989, Mar-15, Volume: 63, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg	1989
A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:1 Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Brain; Brain Injuries; Cells, Cultured; gamma-Ami	1987
Hypertension in renal allograft recipients may be conveyed by cadaveric kidneys from donors with subarachnoid haemorrhage. British medical journal (Clinical research ed.), 1986, Apr-19, Volume: 292, Issue:6527 Topics: Adult; Body Weight; Creatinine; Female; Graft Rejection; Humans; Hypertension; Kidney Transplantatio	1986
Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism. Metabolism: clinical and experimental, 1988, Volume: 37, Issue:3 Topics: Adult; Body Weight; Bone and Bones; Calcium-Binding Proteins; Humans; Male; Methylhistidines; Osteoc	1988
De novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients. Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 3 Topics: Adult; Body Weight; Bone Marrow Transplantation; Creatinine; Cyclosporins; Drug Administration Sched	1988
Weight gain in women with localized breast cancer--a descriptive study. Breast cancer research and treatment, 1988, Volume: 11, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined Modal	1988
Combination of interferon and prednisone in human cancer. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Weight; Drug Tolerance; Humans; Interferon Type	1988
Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Archives of neurology, 1987, Volume: 44, Issue:8 Topics: Adolescent; Body Weight; Child; Child, Preschool; Follow-Up Studies; Humans; Locomotion; Male; Muscu	1987
Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. The Journal of allergy and clinical immunology, 1987, Volume: 80, Issue:4 Topics: Administration, Inhalation; Adolescent; Asthma; Beclomethasone; Blood Cell Count; Body Height; Body	1987
Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet. Archives of disease in childhood, 1986, Volume: 61, Issue:7 Topics: Body Height; Body Weight; Bone and Bones; Calcium, Dietary; Combined Modality Therapy; Female; Human	1986
Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5 Topics: Activities of Daily Living; Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Brea	1986
Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer, 1985, Aug-01, Volume: 56, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined	1985
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood, 1985, Volume: 66, Issue:6 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Blood Cell Coun	1985
Influence of preoperative parenteral alimentation on postoperative growth in adolescent Crohn's disease. Journal of pediatric gastroenterology and nutrition, 1985, Volume: 4, Issue:2 Topics: Adolescent; Age Determination by Skeleton; Body Weight; Crohn Disease; Energy Intake; Follow-Up Stud	1985
Corticosteroid therapy-induced obesity in children. Clinical pediatrics, 1986, Volume: 25, Issue:3 Topics: Adolescent; Body Weight; Child; Child, Preschool; Female; Humans; Infant; Male; Nephrotic Syndrome;	1986
Weight gain during adjuvant chemotherapy for breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:2 Topics: Adult; Aged; Body Weight; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphala	1985
Hypopituitarism and ketotic hypoglycemia. American journal of diseases of children (1960), 1971, Volume: 121, Issue:4 Topics: Acetone; Acidosis; Arginine; Body Height; Body Weight; Child; Fatty Acids, Nonesterified; Female; Gl	1971
The vagaries of Whipple's disease. Southern medical journal, 1971, Volume: 64, Issue:5 Topics: Biopsy; Body Weight; Calcium; Diarrhea; Female; Folic Acid; Humans; Intestinal Mucosa; Jejunum; Midd	1971
Studies on the healing of experimental ulcer in the rat II: influence of anti-inflammatory drugs on the healing of the acetic acid ulcer and the components in gastric tissue. Japanese journal of pharmacology, 1974, Volume: 24, Issue:3 Topics: Acetates; Animals; Anti-Inflammatory Agents; Body Weight; Cortisone; Gastric Mucosa; Hexosamines; Hy	1974
Case for diagnosis: leukocytoclastic vasculitis. Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:5 Topics: Anemia; Arteritis; Blood Sedimentation; Body Weight; Dapsone; Diagnosis, Differential; Humans; Leuko	1973
Changes in blood-volume produced by treatment in the nephrotic syndrome. Lancet (London, England), 1967, Oct-14, Volume: 2, Issue:7520 Topics: Adolescent; Adult; Aged; Blood Volume; Blood Volume Determination; Body Weight; Child; Chlorothiazid	1967
Identical twins with short stature, elevated IgA, and asthma. Annals of allergy, 1967, Volume: 25, Issue:10 Topics: Asthma; Blood Group Antigens; Blood Protein Disorders; Blood Protein Electrophoresis; Body Height; B	1967
Corticosteroids and vascular connective tissue. I. Effects of prednisone on rabbit aorta. Biochemical and morphological studies. Acta endocrinologica, 1969, Volume: 60, Issue:4 Topics: Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Body Weight; Collagen; Connective Tissue; Depress	1969
Effects of glucocorticoid on connective tissue of aorta and skin in rabbits. Biochemical studies on collagen, glycosaminoglycans, DNA and RNA. Acta endocrinologica, 1974, Volume: 77, Issue:2 Topics: Animals; Aorta, Thoracic; Body Weight; Carbon Radioisotopes; Collagen; Connective Tissue; Depression	1974
Hypophosphatasia: clinical and metabolic studies. The Journal of pediatrics, 1968, Volume: 72, Issue:1 Topics: Adolescent; Alkaline Phosphatase; Body Height; Body Weight; Bone Diseases; Calcium; Cephalometry; Ch	1968
[Studies of swine. 23. The effect of long term mineralo- and glucocorticoid application on the behavior of various electrolytes, glucose and leukocytes in the blood as well as 17-ketosteroids in the urine of clinically healthy and bilaterally adrenalectom Archiv fur experimentelle Veterinarmedizin, 1967, Volume: 21, Issue:2 Topics: 17-Ketosteroids; Acetates; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Bloo	1967
[Studies of swine. XXIV. The behavior of various electrolytes, glucose and leukocytes in the blood as well as 17-ketosteroids in the urine of clinically healthy as well as unilaterally and bilaterally adrenalectomized animals after different loading in th Archiv fur experimentelle Veterinarmedizin, 1967, Volume: 21, Issue:2 Topics: 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Blood Glucose;	1967
Studies in 80 per cent pancreatectomized rats of the synergistic interaction of growth hormone, ACTH and the glucocorticoids (corticosterone, cortisol, prednisone and dexamethasone) as diabetogenic agents. Endocrinology, 1971, Volume: 88, Issue:6 Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Cattle; Corticosterone; Dexamethasone; Drug Syner	1971
A controlled transfer from oral corticosteroids to corticotrophin in bronchial asthma. The British journal of clinical practice, 1971, Volume: 25, Issue:9 Topics: Administration, Oral; Adolescent; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Aged;	1971
Effect of prednisone on serum lipids in children with rheumatic fever. Israel journal of medical sciences, 1974, Volume: 10, Issue:5 Topics: Adolescent; Body Weight; Child; Cholesterol; Fatty Acids; Female; Humans; Lipids; Male; Phospholipid	1974
Supression of fetal hematopoeitic development by prednisone treatment of pregnant rats. Experientia, 1974, Sep-15, Volume: 30, Issue:9 Topics: Animals; Animals, Newborn; Body Weight; Bone Marrow; Bone Marrow Cells; Cell Count; Female; Femur; F	1974
[The effect of corticosteroids on bronchial reactivity in children studied by pharmacocapnography]. Orvosi hetilap, 1974, Nov-24, Volume: 115, Issue:47 Topics: Acetylcholine; Asthma; Body Weight; Carbon Dioxide; Child; Humans; Prednisolone; Prednisone; Respira	1974
Use of corticosteroids. Southern medical journal, 1974, Volume: 67, Issue:11 Topics: Addison Disease; Administration, Oral; Adolescent; Adrenocortical Hyperfunction; Age Factors; Asthma	1974
[Radioimmunological determination of somatotropic hormone secretion in premature subjects]. Minerva pediatrica, 1974, May-19, Volume: 26, Issue:18 Topics: Age Factors; Birth Weight; Body Weight; Child; Child, Preschool; Consciousness; Cortisone; Female; G	1974
The biotransformation of cyclophosphamide in man: influence of prednisone. Acta pharmacologica et toxicologica, 1974, Volume: 35, Issue:3 Topics: Adult; Aged; Biotransformation; Body Weight; Carbon Radioisotopes; Cyclophosphamide; Depression, Che	1974
[Therapy of thinness]. Minerva medica, 1972, Apr-25, Volume: 63, Issue:31 Topics: Body Weight; Cyproheptadine; Emaciation; Feeding and Eating Disorders; Fructose; Glucose; Growth; Hu	1972
The treatment of acute leukemia. Rational drug therapy, 1974, Volume: 8, Issue:10 Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Asparaginase; Body Weight; Child; Child,	1974
Aseptic necrosis in the femur after renal transplantation. Annals of surgery, 1972, Volume: 175, Issue:2 Topics: Adult; Age Factors; Body Weight; Bone Diseases; Calcium; Female; Femur; Histocompatibility Testing;	1972
Haemodynamic and blood volume studies in long-term haemodialysis patients, and in patients with successfully transplanted kidneys. Clinical science and molecular medicine. Supplement, 1973, Volume: 45 Suppl 1 Topics: Arteriovenous Fistula; Blood Volume; Body Weight; Chromium Isotopes; Heart Rate; Hematocrit; Hemodyn	1973
[Hydrocortisone therapy of the AGS (adrenogenital syndrome)]. Monatsschrift fur Kinderheilkunde, 1973, Volume: 121, Issue:7 Topics: Adrenal Hyperplasia, Congenital; Androgens; Body Height; Body Weight; Bone Development; Child; Femal	1973
Hiatal hernia and chronic unremitting asthma. Pediatric radiology, 1973, Volume: 1, Issue:3 Topics: Adolescent; Age Factors; Asthma; Body Height; Body Weight; Child; Child, Preschool; Chronic Disease;	1973
[Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1973, Volume: 69, Issue:2 Topics: Acute Disease; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Body Weight; Ed	1973
Hydroxyproline excreted in the urine: its source from collagen of tissues after 14C-proline in rats with and without administration of prednisone. The Journal of clinical endocrinology and metabolism, 1974, Volume: 38, Issue:4 Topics: Animals; Body Weight; Bone and Bones; Carbon Radioisotopes; Collagen; Guinea Pigs; Hydroxyproline; M	1974
Effect of oral prednisone on the measurement of plasma steroid concentrations by the competitive protein-binding radioassay. The Journal of pediatrics, 1974, Volume: 85, Issue:2 Topics: Asthma; Binding, Competitive; Body Weight; Child; Fluorometry; Humans; Hydrocortisone; Methylprednis	1974
Corticosteroid therapy in Felty's syndrome and its effect on hypersplenic rats. British journal of haematology, 1974, Volume: 26, Issue:2 Topics: Aged; Anemia; Animals; Body Weight; Chromium Radioisotopes; Disease Models, Animal; Felty Syndrome;	1974
[Long-term treatment of chronic obstructive lung disease using corticoids]. Vnitrni lekarstvi, 1974, Volume: 20, Issue:2 Topics: Adult; Asthma; Body Weight; Bronchitis; Child; Chronic Disease; Cushing Syndrome; Humans; Prednisone	1974
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days. Canadian Medical Association journal, 1969, Feb-22, Volume: 100, Issue:8 Topics: Azathioprine; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cadaver; Computers; Creatinine; Data	1969
Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma. Blood, 1969, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aged; Body Weight; Cyclophosphamide; Drug Synergism; Hemoglobinometry; Humans; Ly	1969
Skin allografts and immunosuppression in the treatment of massive thermal injury. Surgery, 1969, Volume: 66, Issue:1 Topics: Anesthesia, Inhalation; Animals; Antilymphocyte Serum; Azathioprine; Body Weight; Burns; Guinea Pigs	1969
Oliguria following transplantation of kidneys donated by blood relatives. Surgery, gynecology & obstetrics, 1970, Volume: 130, Issue:1 Topics: Adult; Age Factors; Anuria; Azathioprine; Blood Pressure; Body Weight; Cephalothin; Female; Histocom	1970
Exchangeable potassium in states of adrenocortical dysfunction and in induced hypercortisonism. Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research, 1971, Volume: 16, Issue:3 Topics: Addison Disease; Adolescent; Adrenal Glands; Adrenal Insufficiency; Adrenocortical Hyperfunction; Ad	1971
Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation. Effect of prednisone. Diabetes, 1971, Volume: 20, Issue:6 Topics: Adolescent; Adult; Body Weight; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Hyperglyc	1971
Problems in absorption and immunosuppression after entire intestinal allotransplantation. American journal of surgery, 1972, Volume: 123, Issue:3 Topics: Animals; Azathioprine; Body Weight; Dogs; Graft Rejection; Hematocrit; Immunosuppression Therapy; In	1972
Complications of long-term steroid therapy for asthma. The Journal of allergy and clinical immunology, 1972, Volume: 49, Issue:6 Topics: Adolescent; Adult; Aged; Asthma; Body Fluids; Body Weight; Diabetes Mellitus; Female; Humans; Hypert	1972
Glomerulonephritis and renal tubular acidosis in a case of chronic active hepatitis with hyperimmunoglobulinemia. The American journal of medicine, 1972, Volume: 52, Issue:2 Topics: Acidosis, Renal Tubular; Adolescent; Body Weight; Chronic Disease; Diet; Female; Glomerulonephritis;	1972
Alternate-day corticosteroid regimen. Dermatologica, 1971, Volume: 142, Issue:3 Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Aged; Body Weight; Child; Child, Presc	1971
Varying prednisone dosage in remission induction of previously untreated childhood leukemia. Cancer, 1968, Volume: 21, Issue:3 Topics: Acute Disease; Adolescent; Body Weight; Bone Marrow; Child; Child, Preschool; Humans; Infant; Leukem	1968
Glucocorticoids in nephrology. Acta medica Scandinavica. Supplementum, 1969, Volume: 500 Topics: Adult; Biopsy; Blood Volume; Body Weight; Child; Collagen Diseases; Diuresis; Female; Glucocorticoid	1969
[Weight changes in children treated with corticoids]. Ceskoslovenska pediatrie, 1967, Volume: 22, Issue:12 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Alopecia; Body Weight; Child; Dexamethasone; Female; Hum	1967
[Arthrosis of the knee. Clinical and therapeutic studies]. Hospital (Rio de Janeiro, Brazil), 1969, Volume: 75, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Arthritis; Body Weight; Child; Humans; Joint Diseases; Knee Jo	1969
Effect of complex formation on drug absorption. Acta pharmacologica et toxicologica, 1971, Volume: 29 Suppl 3 Topics: Amides; Animals; Antipyrine; Body Weight; Caffeine; Cyprinidae; Drug Interactions; Hydrogen-Ion Conc	1971
Function of a transplanted kidney. Polish medical journal, 1967, Volume: 6, Issue:2 Topics: Adult; Azathioprine; Body Weight; Female; Glomerulonephritis; Humans; Immune Tolerance; Kidney; Kidn	1967
Growth effects of long-term antileukemic therapy. The Journal of pediatrics, 1969, Volume: 75, Issue:6 Topics: Adolescent; Adrenal Cortex Hormones; Body Height; Body Weight; Child; Child, Preschool; Cyclophospha	1969
Adrenal venography in virilized women. JAMA, 1970, Sep-07, Volume: 213, Issue:10 Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neopla	1970
Chronic beryllium disease: a new case following exposure in 1961. British journal of diseases of the chest, 1970, Volume: 64, Issue:3 Topics: Adult; Berylliosis; Body Weight; Carbon Dioxide; Chemical Industry; Chronic Disease; Environmental E	1970
[Studies on the glucose tolerance in childhood using various loading tests]. Archiv fur Kinderheilkunde, 1970, Volume: 181, Issue:2 Topics: Administration, Oral; Age Factors; Blood Glucose; Body Weight; Diabetes Mellitus; Glucose Tolerance	1970
[Nitrogen resorption and nitrogen retention in patients with chronic liver diseases]. Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1970, Volume: 30, Issue:1 Topics: Anabolic Agents; Body Weight; Calorimetry; Chronic Disease; Depression, Chemical; Diet Therapy; Fece	1970
The effect of prednisone on plasma norepinephrine concentration and renin activity in salt-depleted man. The Journal of laboratory and clinical medicine, 1971, Volume: 77, Issue:2 Topics: Adult; Body Weight; Creatinine; Diet, Sodium-Restricted; Hematocrit; Humans; Male; Norepinephrine; N	1971
[Effect of steroid therapy in combination with vitamin B 12, folic acid, nicotinic acid and vitamin C on the course of carbon tetrachloride-induced cirrhosis. Studies in experimental animals]. Die Medizinische Welt, 1971, Feb-06, Volume: 6 Topics: Anabolic Agents; Animals; Ascorbic Acid; Body Weight; Carbon Tetrachloride Poisoning; Drug Synergism	1971
Pericarditis in chronic uremia and its sequels. Annals of internal medicine, 1971, Volume: 75, Issue:2 Topics: Adolescent; Adult; Age Factors; Arrhythmias, Cardiac; Autopsy; Blood Urea Nitrogen; Body Weight; Chr	1971
[Progressive chronic polyarthritis and active body mass]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1971, Jan-15, Volume: 26, Issue:2 Topics: Adipose Tissue; Adult; Arthritis, Rheumatoid; Body Weight; Chloroquine; Creatinine; Humans; Methods;	1971
Polyarthritis in obese patients with intestinal bypass. Annals of internal medicine, 1971, Volume: 75, Issue:3 Topics: Adolescent; Adult; Arthritis; Aspirin; Body Height; Body Weight; Colon; Dehydration; Female; Humans;	1971
Natural history of lipoid nephrosis and of membranous glomerulonephritis. Annals of internal medicine, 1968, Volume: 69, Issue:6 Topics: Adolescent; Adult; Aged; Basement Membrane; Biopsy; Body Weight; Child; Child, Preschool; Cholestero	1968
Tuberculosis, corticosteroid therapy, and pulmonary function. The American review of respiratory disease, 1969, Volume: 100, Issue:1 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Body Weight; Carbon Dioxide; Female; Humans; Lung; M	1969
[On prednisone therapy of Blackfan-Diamond anemia]. Deutsche medizinische Wochenschrift (1946), 1966, Sep-30, Volume: 91, Issue:39 Topics: Anemia, Aplastic; Blood Chemical Analysis; Blood Coagulation Tests; Blood Transfusion; Body Weight;	1966
Vaccination of a patient receiving immunosuppressive therapy for lymphosarcoma. JAMA, 1966, Nov-14, Volume: 198, Issue:7 Topics: Agammaglobulinemia; Aged; Animals; Autoimmune Diseases; Body Weight; Female; Globulins; Guinea Pigs;	1966
[Group drug therapy in acute leukemia in childhood. Report of experiences in the USA]. Medizinische Klinik, 1966, Feb-04, Volume: 61, Issue:5 Topics: Ambulatory Care; Animals; Body Height; Body Weight; Bone Marrow Examination; Child; Humans; Leukemia	1966

prednisone and Body Weight

Research Excerpts

Research

Studies (207)

Authors

Clinical Trials (9)

Trial Overview

Trial Outcomes

Expression of GALGT2 as Demonstrated by Immunofluorescent Staining With Anti-CT Epitope Antibodies or WFA Lectin in Muscle Biopsy Sections at 120 Days Post Injection (Cohort 1) and 90 Days Post-injection (Cohort 2).

GALGT2 Protein Expression Quantified by Western Blot and Assessed by Densitometry in Muscle Biopsy Tissue at 120 Days Post-injection (Cohort 1) and 90 Days Post-injection (Cohort 2)

Number of Unanticipated Grade III or Higher Treatment-Related Toxicities

Number of Meters Walked During the 6 Minute Walk Test

Score of Muscle Function Using the The North Star Ambulatory Assessment (NSAA).

Strength of the Bilateral Knee Flexors and Extensors During the Maximal Voluntary Isometric Strength Test.

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

6 Minute Walk Test

Forced Vital Capacity

Fractional Shortening Percent

Heart Rate

Left Ventricular Ejection Fraction Percent

North Star Ambulatory Assessment (NSAA) Score

Number of Participants Who Tolerated the Regimen

Participant Body Mass Index

Participant Height

Participant Weight

PR Interval

Quality of Life - Parent

Quality of Life- Child

Range of Motion (Goniometry) of Left Ankle

Range of Motion (Goniometry) of Right Ankle

Rise From the Floor Velocity

Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction With Treatment Score

Reviews

Trials

Other Studies

Intervention	score on a scale (Least Squares Mean)
Daily Prednisone	71.2
Daily Deflazacort	67.8
Intermittent Prednisone	65.1